MHIC
TEVA icon

Marble Harbor Investment Counsel’s Teva Pharmaceuticals TEVA Stock Holding History

Marble Harbor Investment Counsel’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-22,625
Closed -$398K – 159
2017
Q3 		$398K Sell
22,625
-300
-1% -$6.75K 0.08% 118
2017
Q2 		$762K Sell
22,925
-350
-2% -$10.8K 0.17% 84
2017
Q1 		$747K Sell
23,275
-1,250
-5% -$42.7K 0.16% 84
2016
Q4 		$889K Sell
24,525
-450
-2% -$18K 0.2% 74
2016
Q3 		$1.15M Sell
24,975
-3,550
-12% -$185K 0.27% 66
2016
Q2 		$1.43M Sell
28,525
-450
-2% -$24K 0.35% 60
2016
Q1 		$1.55M Sell
28,975
-5,600
-16% -$329K 0.38% 56
2015
Q4 		$2.27M Sell
34,575
-100
-0.3% -$6.18K 0.6% 44
2015
Q3 		$1.96M Sell
34,675
-560
-2% -$36.3K 0.54% 48
2015
Q2 		$2.08M Sell
35,235
-1,100
-3% -$67.9K 0.53% 48
2015
Q1 		$2.26M Sell
36,335
-340
-0.9% -$19.8K 0.57% 45
2014
Q4 		$2.11M Sell
36,675
-450
-1% -$25.1K 0.48% 51
2014
Q3 		$2M Sell
37,125
-550
-1% -$29.1K 0.48% 53
2014
Q2 		$1.98M Hold
37,675
– – 0.47% 53
2014
Q1 		$1.99M Hold
37,675
– – 0.52% 53
2013
Q4 		$1.51M Sell
37,675
-455
-1% -$17.9K 0.4% 59
2013
Q3 		$1.44M Sell
38,130
-900
-2% -$35.1K 0.41% 57
2013
Q2 		$1.53M Buy
+39,030
New +$1.52M 0.46% 56

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
BC
Brahman Capital New York $275M AUM 18.08% 1-Year Est. Return

Marble Harbor Investment Counsel's TEVA Position: Q4 2017 in Review

Marble Harbor Investment Counsel sold out of Teva Pharmaceuticals (TEVA) in Q4 2017, closing a stake of 22,625 shares — an estimated $398K sold.

Marble Harbor Investment Counsel first reported a position in TEVA in Q2 2013 and held it in 18 quarters. The position peaked at $2.27M in Q4 2015. 508 funds tracked by Wall St. Rank hold TEVA as of Q4 2017.

  • Marble Harbor Investment Counsel reported no remaining Teva Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • Marble Harbor Investment Counsel sold 22,625 Teva Pharmaceuticals shares in Q4 2017, an estimated $398K.
  • Marble Harbor Investment Counsel first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 18 quarters.
  • Marble Harbor Investment Counsel's Teva Pharmaceuticals position peaked at $2.27M in Q4 2015.
  • 508 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2017.

Based on Marble Harbor Investment Counsel's 13F filing for Q4 2017, filed 6 Feb 2018.